Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals
2008 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
CRNX STOCK SYMBOL
$18.37 SHARE PRICE (As of Thursday Closing)
Description

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 10222 Barnes Canyon Road
  • Building No. 2
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Crinetics Pharmaceuticals’s full profile, request a free trial.

Crinetics Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$14.33 - $36.95 $445M $19.18 -$1.84 56.5K 24.2M

Crinetics Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 224,898 551,215
Revenue 1,653 2,428 2,045 589
EBITDA (47,306) (28,392) (9,047) (5,953)
Net Income (44,368) (27,115) (9,157) (6,019)
Total Assets 142,509 171,415 15,598 12,599
Total Debt 5,740 212
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Crinetics Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Crinetics Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Crinetics Pharmaceuticals Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Protagonist Therapeutics Formerly VC-backed Newark, CA 00 00000 000000000 00000
0000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
00000 Venture Capital-Backed Pittsburgh, PA 00 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000
To view this company’s complete list of competitors, request access »

Crinetics Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Crinetics Pharmaceuticals Executive Team (7)

Name Title Board
Seat
Contact
Info
Yun-Fei Zhu Ph.D Founder & Vice President
Ajay Madan Ph.D Vice President
Stephen Betz Ph.D Vice President
Richard Struthers Ph.D Co-Founder, Chief Executive Officer & Board Member
Marc Wilson Chief Financial Officer & Chief Accounting Officer

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

Crinetics Pharmaceuticals Board Members (10)

Name Representing Role Since Contact
Info
David Allison Ph.D 5AM Ventures Board Observer 000 0000
Jack Bech Nielsen Vivo Capital Board Member 000 0000
Matthew Fust Self Board Member 000 0000
Richard Struthers Ph.D Crinetics Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Stephen Kaldor Ph.D Versant Venture Management Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »